Neurological disorders are incredibly complex, and this is reflected in the lack of knowledge of the underlying pathological mechanism for many of these diseases, and in turn to the slow speed at which novel drug targets are identified. Mark Aurousseau at eNUVIO reveals that regardless, research in the field remains vibrant, and the emergence of novel research technologies and tools continues to lead to exciting discoveries that hold promise to translate into the development of novel therapeutics.